Background and Purpose-The cerebrovascular contribution to ischemic preconditioning (IPC) has been scarcely explored. Using in vivo and in vitro approaches, we investigated the involvement of the blood-brain barrier and the role of its cellular components. Methods-Seven-minute occlusion of the right middle cerebral artery, used as in vivo IPC stimulus 4 days before permanent occlusion of the right middle cerebral artery, significantly reduced brain infarct size (8.45Ϯ0.7 versus 13.61Ϯ0.08 mm
T he concept of neuroprotection in ischemic preconditioning (IPC) is based on the observation that a brief, noninjurious stimulus protects the brain from a subsequent severe insult. 1, 2 Experimental IPC also has a human counterpart, as transient ischemic attacks may be associated with a better prognosis after a subsequent stroke. 3, 4 In vitro and in vivo IPC models have mostly focused on neurons as cellular targets of cerebral IPC, but little attention has been paid so far to the cerebrovascular compartment, even though it plays a crucial role in the pathogenesis of ischemic brain injury. 5 Endothelial cells of the cerebral microvasculature are the main component of the blood-brain barrier (BBB), and their close association with astrocyte endfeet, pericytes, and microglia is essential for the maintenance of the nervous system microenvironment. 6 It is known that IPC stimuli may attenuate BBB disruption and brain edema. 7, 8 In addition, brain endothelial cells can be preconditioned, an effect associated with stabilization of tight junction (TJ) proteins 9 and/or activation of the phosphatidylinositol-3 kinase/Akt pathway. 10, 11 However, little is known about the contribution of glial cells to BBB preconditioning. By in vivo and in vitro approaches, this study aimed at evaluating the functional effects of IPC on the BBB and the role of its cellular components in mediating IPC-induced protection.
Methods

Animals
C57BL/6 mice (Harlan Laboratories, Italy) were housed in an Specific Pathogen Free (SPF) vivarium. Procedures involving animals and their care were conducted in conformity with institutional guidelines that are in compliance with national and international laws and policies. 12 
In Vivo Ischemia
Anesthesia was induced by 3% isoflurane inhalation in an N 2 O/O 2 (70%:30%) mixture and maintained by 1% to 1.5% isoflurane inhalation in an N 2 O/O 2 (70%:30%) mixture. Transient ischemia was induced in mice by means of a siliconized filament (7-0, Doccol Corp, Redlands, CA) introduced into the right middle cerebral artery (MCA) 13, 14 for 10, 7, or 5 minutes as an IPC stimulus. Severe ischemia was obtained through permanent occlusion of the right MCA (pMCAo) by electrocoagulation 12 in mice anesthetized with equitensin (100 L IP per mouse). For both surgical procedures, sham-operated mice received identical anesthesia and surgery without artery occlusion.
Quantification of Infarct Size
Twenty-micron coronal brain sections obtained from perfused brains were cut and stained with neutral red (neutral red Gurr Certistain, BDH, Poole, UK). Infarct volumes were calculated by the integration of infarct areas on each brain slice, as previously described. 15 
Evans Blue-Albumin Leakage
Quantitative evaluation of BBB disruption was achieved by measuring Evans blue-labeled albumin leakage in ischemic brains 16 (further details are provided in supplemental Methods, http://stroke.ahajournals.org).
In Vitro BBB Model
Cocultures of brain microvessel endothelial cells, obtained from 8-week-old mice and grown on transwell inserts, and astroglial cells, obtained from 24-to 48-hour newborn mice and grown on the bottom of multiwell plates, were prepared 6 (further details in supplemental Methods and supplemental Figure S1 ).
In Vitro Ischemia
Cocultures were exposed to oxygen-glucose deprivation (OGD; further details in supplemental Methods) according to the following protocols: 1-hour OGD (IPC group), 5-hour OGD (OGD group), or 1-hour OGD followed by 5-hour OGD 24 hours later (1-hourϩ5-hour OGD group) for IPC assessment. Subsequently, to discriminate between the selective contribution of endothelial and glial cells to the IPC-induced protection, the IPC stimulus (1-hour OGD) was delivered separately to either endothelial or glial cells. After the IPC stimulus, the preconditioned endothelial cells were placed together with nonpreconditioned glial cells (endo IPC), whereas nonpreconditioned endothelial cells were placed together with preconditioned glial cells (glia IPC). Twenty-four hours later, the cocultures were exposed to 5-hour OGD.
Immunostaining
Brain microvessel endothelial cells were fixed with ice-cold ethanol for 30 minutes at 4°C. Rabbit anti-ZO-1 (1:100; Zymed, CA) and rabbit anti-claudin-5 (1:100; Zymed) were used as primary antibodies (overnight at 4°C). Anti-rabbit Alexa 594 (1:100, Molecular Probes, CA) was used as a secondary antibody. Immunofluorescence staining was assessed by using an Olympus IX81 microscope equipped with an Olympus confocal FV500 scan unit. 12 
Lactate Dehydrogenase Assay
Lactate dehydrogenase (LDH) activity in cell culture media was measured with a commercially available kit (CytoTox 96; Promega, Madison, WI), according to the manufacturer's instructions.
Fluorocitrate Treatment
Fluorocitrate (FC; Sigma, St. Louis, MO) was prepared as described by Voloboueva et al 17 to reach a final concentration of 0.48 mmol/L. Cells were exposed to FC for 3 hours, that is, 2 hours before and during 1 hour of IPC. Afterward, the medium containing the FC was replaced with fresh, normoglycemic medium, and the FCpreconditioned glial cells were cocultured together with nonpreconditioned endothelial cells.
Measurements of ATP Levels
Cellular ATP concentration was measured with the CellTiter-Glo luminescent ATP assay kit, based on the luciferase/luciferin reaction (Promega) according to the manufacturer's instructions. AVeritas luminescence counter (Turner BioSystems, Sunnyvale, CA) was used to measure the luminescence signal of the samples in white, opaque 96-well plates. ATP content was reported as luminescence units.
RNA Isolation, cDNA Synthesis, and Real-Time Polymerase Chain Reaction
Forty-eight hours after pMCAo or sham operation, the cortical mRNA expression of the following genes was analyzed 18 : highmolecular-weight subunit of neurofilaments and microtubuleassociated protein-2 (neuronal markers); CD31 (endothelial marker); glial fibrillary acidic protein (GFAP; astrocyte marker), CD11b and CD68 (microglia/macrophage markers); and oligodendrocyte lineage transcription factor-2 and NG2 (oligodendrocyte markers). In glial cell cultures, the mRNA expression of selected genes considered to be markers of functional astrocytic phenotypes (GFAP, vascular endothelial growth factor-a, interelukin-6, and ciliary neurotrophic factor) were analyzed. The primers used are reported in supplemental Table S1 (further details in supplemental Methods).
Statistical Analysis
One-way ANOVA with a Dunnett post hoc test was used for the time window of efficacy, a 1-way ANOVA with a Tukey post hoc test was used for gene expression, and an unpaired t test was used for Evans blue-albumin leakage and ATP content. Two-way ANOVA with a Bonferroni post hoc test was used for transendothelial electric resistance (TEER), and 1-way ANOVA with a Bonferroni post hoc test was used for TEER, endothelial permeability coefficients (Pe), and LDH analyses.
Results
In Vivo IPC Model
Short, transient MCAo (10, 7, or 5 minutes) was delivered to mice as the IPC stimulus. Forty-eight hours later, mice were evaluated for neurologic deficits, ischemic volumes (by neutral red staining), and the presence of neurodegenerating cells (by fluoro-Jade staining). The 7-minute, transient MCAo (7ЈMCAo) was chosen as the IPC stimulus because it was the longest noninjurious stimulus 1 (Supplemental Table S2 ).
pMCAo was delivered as severe ischemia and was performed at different time points (1, 2, 3, 4, or 5 days) after 7ЈMCAo ( Figure 1A ). When pMCAo was performed 3 or 4 days after 7ЈMCAo, a significant reduction in the ischemic volume, assessed 7 days later, was observed (8.95Ϯ1.02 and 8.45Ϯ0.7 mm 3 , respectively) compared with ischemic mice not exposed to 7ЈMCAo (13.61Ϯ.08 mm 3 ; Figure 1B and 1C). Then BBB involvement in 7ЈMCAo-induced neuroprotection was evaluated by measuring Evans blue-albumin leakage 20 hours after pMCAo in preconditioned and nonpreconditioned mice at the time of maximal protection (4 days after 7ЈMCAo). Mice that had previously undergone sham occlusion (sham 7ЈMCAo) had marked BBB disruption 20 hours after a subsequent pMCAo (0.89Ϯ0.1 ng/mg). This was significantly attenuated in the 7ЈMCAo-treated group (0.54Ϯ0.1 ng/mg; Figure 1D ).
To evaluate the contribution of the different cell populations of the cerebrovascular unit to the in vivo IPC, we next analyzed the cortical mRNA expression of genes that are considered to be markers of different cell types or phenotypes 2 days after pMCAo. As expected, pMCAo significantly increased CD11b, CD68, CD31, and GFAP expression compared with sham operation. pMCAo also decreased microtubule-associated protein-2 while leaving highmolecular-weight subunit of neurofilaments, NG2 and oligodendrocyte lineage transcription factor-2 unaffected ( Figure  2 ). Previous exposure to 7ЈMCAo affected GFAP only, whose expression was significantly increased in preconditioned compared with nonpreconditioned mice (Figure 2 ).
In Vitro BBB Model
After 2 to 3 days of coculture, brain microvessel endothelial cells expressed the endothelial marker CD31 (Supplemental Figure S1 ). In addition, brain microvessel endothelial cells retained the features of a functional BBB 6 in mice, that is, typical values of TEER (228Ϯ 6.44 ⍀cm 2 ), Pe for paracellular (sodium fluorescein Pe, 0.53Ϯ0.02ϫ10
Ϫ3 cm/min) and transcellular (albumin Pe, 0.02Ϯ0.005ϫ10
Ϫ3 cm/min) transport, and continuous intercellular staining of TJ proteins, namely, ZO-1 and claudin-5 (an intracellular and a transmembrane protein, respectively), which contribute to the tightness of the BBB-endothelial cells (supplemental Figure S1 ).
BBB Preconditioning
The experimental plan is detailed in Figure 3A . Five Figure 3B ). When 1-hour OGD was performed 24 hours before a severe 5-hour OGD, significant attenuation of the 5-hour OGD-dependent effect was observed at every time point tested (after OGD, 161.47Ϯ8.41; 24 hours after OGD, 199.17Ϯ11.7; and 48 hours after OGD, 175.84Ϯ7.11 ⍀cm 2 ; Figure 3B ).
Twenty-four hours after the 5-hour OGD, a significant increase in Pe for both sodium fluorescein (1.8Ϯ0.36ϫ10 Ϫ3 and albumin, 0.09Ϯ0.002ϫ10
Ϫ3 cm/min). Cocultures exposed to 1-hourϩ5-hour OGD had significantly lower Pe values both for sodium fluorescein (0.98Ϯ0.11ϫ10
Ϫ3 cm/min) and albumin (0.12Ϯ0.01ϫ10
Ϫ3 cm/min) compared with those exposed to severe OGD alone ( Figure 3C ).
With regard to cell viability, cocultures exposed to 5-hour OGD showed a significant increase in LDH release (optical density [OD]ϭ1.97Ϯ0.09) compared with control cells (ODϭ 1.1Ϯ0.08), whereas 1-hour OGD did not cause significant changes in LDH release (ODϭ1.44Ϯ0.08; supplemental Figure  S2 ). Cocultures exposed to 1-hourϩ5-hour OGD showed a significant decrease in LDH release (ODϭ0.84Ϯ0.004) compared with 5-hour OGD alone (supplemental Figure S2) .
The presence and distribution of TJ proteins were also assessed. Control cells showed an intense and continuous staining of ZO-1 and claudin-5 at the cell borders ( Figure  3D ). Five-hour OGD resulted in decreased immunostaining intensity and loss of the continuous junctional distribution, whereas 1-hour OGD did not affect them. Staining intensity and distribution of TJs in the cocultures exposed to 1-hourϩ5-hour OGD were similar to the control condition ( Figure 3D ).
Contribution of BBB Cell Populations to IPC
The experimental plan is detailed in Figure 4A . IPC delivered to glial cells alone was significantly more effective in damping the drastic reduction in TEER induced by the subsequent severe OGD, compared with IPC delivered to endothelial cells alone ( Figure 4B ). The effect was already visible 24 hours after severe OGD when glia IPC, but not endo Figure 4B ).
The prominent contribution of glial cells to IPC was also indicated by permeability assessment, performed 24 hours after OGD ( Figure 4C Figure 4C ). Regarding cell viability, both glia IPC and endo IPC showed a significant reduction in LDH release compared with OGD (ODϭ0.7Ϯ0.03, 0.72Ϯ0.03, and 1.88Ϯ0.02, respectively; supplemental Figure S3 ). The analysis of ZO-1, evaluated 48 hours after OGD, showed that its intensity and distribution in glia IPC were similar to those of controls, whereas endo IPC was similar to OGD ( Figure 4D ).
The role of astrocytes in mediating IPC protective effects was further assessed by exposing glial cells to the mitochondrial inhibitor FC during IPC. FC treatment significantly decreased cellular ATP content, whereas it did not affect cell Figure 5B ) and the increase in Pe values for sodium fluorescein (1.8Ϯ0.2ϫ10 Ϫ3 versus 1.3Ϯ0.1ϫ10 Ϫ3 cm/min; Figure  5C ) of glia IPC FC-treated cells compared with the glia IPC group performed 24 hours after OGD. Forty-eight hours after OGD, ZO-1 intensity and distribution in glia IPC FC-treated cells were similar to those after OGD, whereas glia IPC was similar to control cells ( Figure 5D ).
To evaluate the molecular mechanisms involved in the prominent contribution of glial cells to IPC, immediately after OGD, we analyzed the mRNA expression of gene markers of functional astrocytic phenotypes. First, confirming our in vivo data, we observed that IPC induced a significant rise in GFAP after OGD compared with OGD alone (Figure 6 ). In addition, we also observed that IPC caused an increase in interleukin-6, vascular endothelial growth factor-a, and ciliary neurotrophic factor gene expression ( Figure 6 ).
Discussion
By using in vivo and in vitro approaches, this study has demonstrated the involvement of the cerebrovascular unit in IPC and emphasizes the role of astrocytes in driving the IPC-induced protective effect. The involvement of the BBB in IPC was first studied in an in vivo IPC model. According to the definition of IPC stimulus, 1 we delivered 7 minutes of IPC on glial cells alone was significantly more effective in damping the drastic reduction in transendothelial electric resistance (TEER) induced by the subsequent severe oxygen-glucose deprivation (OGD) compared with that on endothelial cells alone (B). Both paracellular and transcellular transports were not affected by OGD when glial cells alone, but not endothelial cells alone, had been exposed to IPC (C). The staining intensity and distribution of ZO-1 were similar to control condition when glial cells alone had been exposed to IPC (glia IPC), whereas they were similar to OGD when endothelial cells alone had been exposed to OGD (endo IPC) (D). Data are reported as meanϮSEM, nϭ12. ###PϽ0.001, ##PϽ0.01 vs OGD;°°°PϽ0.001,°°PϽ0.01 vs endo IPC; ***PϽ0.001 vs glia IPC, 2-way ANOVA followed by Bonferroni test for TEER at 48 hours after OGD and 1-way ANOVA followed by Bonferroni test for endothelial permeability coefficient (Pe). Scale barϭ50 m. LDH indicates lactate dehydrogenase; TJ, tight junction; and CTR, control.
ischemia, representing the longest period of MCAo not associated with damage. This IPC stimulus reduced the ischemic volume (as assessed 7 days after injury) induced by a subsequent severe ischemia, and its protective effects were maximal when the IPC stimulus was delivered 4 days before pMCAo. We observed a significant reduction in BBB leakage in IPC compared with non-IPC mice. Because events occurring at the BBB as a consequence of ischemia represent major players in ischemic injury, the protective effects observed in IPC brains can be a consequence of the protective phenotype assumed by the BBB. To elucidate the selective involvement of the different brain cell populations in IPC in vivo, we analyzed gene expression for the neuronal, endothelial, and glial components. Gene expression analysis showed that only GFAP was selectively upregulated in IPC-protected mice, whereas neuronal, endothelial, microglial, and oligodendrocytic components did not appear to be involved. These findings suggest that astrocytes may have an important role in mediating BBB IPC. To further define the contribution of the BBB cell populations to IPC and to evaluate the molecular mechanisms involved in the IPC-induced protective effects, we then studied an in vitro model.
Importantly, the BBB model that we used retained the features of a functional BBB. 6 Although one cannot rule out that physiologic features of the endothelial cells used in this system might be lost in vitro, findings in the present and previous studies 6 indicate that these cells retain an endothelial-specific phenotype, as assessed by the expression of certain markers (that is, CD31/Platelet Endothelial Cell Adhesion Molecule-1 and claudin-5), as well as the ability to form a functionally tight barrier (that is, high TEER and low Pe values). Finally, with all the caveats of transferring in vitro data to the in vivo situation, available evidence supports the notion that astrocytes provide the cocultured endothelial cells with factors that help maintain their vascular phenotype. 19 By using the in vitro BBB model, we showed that a subthreshold stimulus consisting of a short OGD protects To elucidate the contribution of endothelial and glial cells to the observed IPC-induced protective effects, the 2 BBB cell populations were exposed separately to the IPC stimulus. Preconditioned glial cells were much more efficient in eliciting the IPC protective phenotype than were endothelial cells. Specifically, when IPC was performed on glial cells alone, the BBB showed greater resistance to severe OGD, compared with the IPC performed on endothelial cells alone. It is likely that molecules produced by glial cells (either during IPC or in the following 24 hours that preceded severe OGD) are able to induce a protective BBB phenotype. Notably, the transient metabolic inhibition of astrocytes induced by FC treatment during IPC prevented the IPC protective effects on the BBB, further confirming the crucial role of astrocytes in mediating BBB protection. These results fully support the in vivo finding that astrocytes are major players in the BBB protective mechanisms activated by IPC.
Thus, this study shows for the first time that astrocytes are required for triggering an effective IPC on BBB cells. Maintenance of BBB properties is 1 of the several protective actions attributed to these cells that, with their endfeet surrounding endothelial cells on 1 side and reaching neurons on the other, are ideally situated to control metabolic supply, blood flow, ionic homeostasis, and neurotransmitter levels. 20, 21 Actually, glial cells have been shown to affect endothelial cells differently under different conditions. They can either worsen the ischemia-induced increase in endothelial permeability 22 or protect them from pathologic stimuli, that is, from lipopolysaccharide-induced damage. 23 Several mechanisms may contribute to the IPC-induced protective effect described. An increased expression of GFAP has been associated with a functional phenotype characterized by expression of specific molecules acting as inflammatory regulators, like interleukin-6, or playing a trophic role, like ciliary neurotrophic factor 20 and vascular endothelial growth factor, which are endowed with protective actions on the BBB. 24 Our data provide evidence that all of these molecular pathways are involved in the prominent contribution of glial cells to IPC, as shown by the significant increase in interleukin-6, vascular endothelial growth factor, and ciliary neurotrophic factor gene expression occurring after OGD.
In conclusion, we have shown that the BBB can be preconditioned and that astrocytes are a major driving gear in this mechanism, as IPC delivered to glial cells is strictly required for preventing the functional damage of the BBB. Promotion of the astrocytic signaling pathways that ultimately lead to an ischemia-tolerant phenotype may serve as a therapeutic tool for neurovascular unit protection in stroke patients.
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Supplemental Methods
Evans blue-albumin leakage Quantitative evaluation of BBB disruption was achieved by measuring Evans blue-labelled albumin leakage in the ischemic hemispheric tissue 7, 8 . Evans blue dye (2% wt/vol in PBS) was administered (150 µl/mouse) via the tail vein 1.5h before sacrifice. Twenty hours after pMCAo, mice were transcardially perfused with cold PBS to remove intravascular Evans blue dye. Quickly after transcardial perfusion non ischemic and ischemic hemispheric tissues were weighed and homogenized in 1 ml of 50% trichloroacetic acid (Sigma, St. Louis, MO, USA) to precipitate proteins. After centrifugation (20min at 10,000 rpm), the supernatants were read by a microplate fluorescence reader (Tecan Infinite M200, Switzerland, excitation at 620 nm and emission at 680 nm). The total Evans blue-albumin content (ng) in each sample was derived from the concentrations of external standards (10 -10 000 ng/mL). The difference between ischemic and non ischemic hemispheric tissue was calculated as Evans blue-albumin leakage and expressed as ng per milligram of brain tissue (ng/mg).
Fluoro-Jade labeling
To label degenerating neurons, Fluoro-Jade (FJ) staining was carried out on 20µm sections as previously described 11, 12 . The presence of FJ positive cells was then evaluated using a fluorescent microscopy (Olympus, BX61, Japan).
Neurological Deficits
Two days after 10', 7' or 5' MCAo each mouse was rated on two neurological function scales unique to the mouse. For general deficits mice were scored from 0 to 28 in each of the following categories: hair, ears, eyes, posture, spontaneous activity, epileptic behavior. For focal deficits mice were scored from 0 to 28 in each of the following categories: body symmetry, gait, climbing, circling behavior, front limb symmetry, compulsory circling and sensory response as previously described 11 .
BBB in vitro model
Primary cultures of astroglial cells were prepared from 24-48h newborn mice 1 . Brains were collected, meninges removed and cortical pieces were mechanically dissociated and incubated for 15min at 37°C with trypsin (2.5mg/ml; Invitrogen, CA, USA) and DNAse I (0.08mg/ml; Sigma, MO, USA). Supernatant containing the astroglial cells was collected, centrifugated and resuspended in DMEM containing 0.5mg/ml gentamicin (Sigma, MO, USA) and 10% fetal bovine serum (FBS, HyClone, MA, USA). Cells were seeded on poly-L-lysin (Sigma, MO, USA) coated 12-well plates. Astroglial cells were cultured for 3 weeks before use. Immunostaining performed at this time showed that about 90% of the cells were GFAP-positve astrocytes while the remaining 10% were positive for APC, a marker of oligodendrocytes and for CD11b, a marker of microglial cells (Fig. S1 ). Brain microvessel endothelial cells (BMECs) were prepared from 8 week-old male mice 2 . Forebrains were collected in ice cold sterile phosphate buffered saline (PBS) and meninges removed. Subsequently the gray matter was minced by scalpels to 1 mm 3 pieces and digested with 1 mg/ml collagenase CLS2 (Worthington, NJ, USA) in Dulbecco's modified Eagle medium (DMEM, Invitrogen, CA, USA) for 45min at 37 °C. Microvessels were separated by centrifugation in 20% bovine serum albumin (BSA, Sigma, MO, USA)-DMEM (1000 x g, 20min) from myelin containing elements, and further digested with 1 mg/ml collagenase-dispase (Roche, Mannheim, Germany) in DMEM for 30min to remove pericytes from the basal membrane. Microvascular endothelial cell clusters were separated on a 33% continuous Percoll (Amersham, NJ, USA) gradient, collected, and seeded on collagen type IV and fibronectin coated cell culture inserts (Transwell clear, 1.12 cm 2 ; pore size, 0.4 μm, Costar, MA, USA). Cultures were maintained in DMEM supplemented with 5 μg /ml gentamicin (Sigma, MO, USA), 20% plasma-derived bovine serum (PDS, First Link, UK), 200 μg/ml endothelial cell growth supplement (ECG, Sigma, MO, USA) and 100 μg/ml heparin. In the first 2 days, culture medium contained 4 μg/ml puromycin (Sigma, MO, USA) to selectively remove P-glycoprotein negative contaminating cells 3 . Cultures reached confluency within 4-5 days and were used for experiments. To induce BBB characteristics, BMECs were co-cultured with mouse cerebral astroglial cells 2, 4 . Two days after seeding, the transwell inserts containing the BMECs were placed into multiwell plates containing astroglia at the bottom of the wells and the culture medium was replaced with fresh endothelial culture medium added with hydrocortisone (Sigma, MO, USA) at a physiological concentration of 550 nM in both compartments to improve barrier properties 4, 5 . Twenty-four hours later, culture medium was added with CPT-cAMP 250 μM (Sigma, MO, USA) and RO 201724 17.5 μM (Sigma, MO, USA) for 24h to tighten junctions and elevate resistance 3, 4, 6 . Culture medium was replaced 24h later with fresh medium culture without any additional drugs and the cells were ready for the experiments.
Measurement of monolayer resistance and permeability TEER, representing the permeability of TJs for sodium ions, was measured by an EVOM resistance meter (World Precision Instruments, FL, USA) using STX-2 electrodes and was expressed relative to the surface area of endothelial monolayer (Ωcm 2 ). The TEER of cell-free inserts (80-90 Ωcm 2 ) was subtracted from the values. For permeability measurements the flux of Na-fluorescein (Sigma, MO, USA) and that of peroxidase-conjugated albumin (Jackson ImmunoResearch, PA, USA) across endothelial monolayers was determined as previously described 1 . Cell culture inserts with the endothelial cells were transferred to 12-well plates containing 1.5 ml/well of DMEM without phenol red. In upper chambers culture medium was replaced by 500 µl DMEM without phenol red containing 10 µg/ml Na-fluorescein (MW: 376 Da) and 0.5 µg/ml of peroxide albumin (MW: 67 kDa). After 15, 30, 60, 120 and 240 min the inserts were transferred to a new well containing DMEM without phenol red. The concentrations of the marker molecules were determined in samples obtained from the lower compartments. Albumin and Na-fluorescein concentrations were measured by a TECAN plate reader (Infinite M200, Switzerland, absorbency: 450nm for Albumin and emission: 515 nm, excitation: 460 nm for Na-fluorescein). Flux across cell-free inserts was also measured. Transport was expressed as 'µl' of donor (upper) compartment volume from which the tracer is completely cleared The average cleared volume was plotted versus time, and permeability x surface area product value for endothelial monolayer (PSe) was calculated by the following formula: PS
PSe divided by the surface area generated the endothelial permeability coefficient (Pe, in 10
cm/min).
In vitro ischemia
In vitro ischemia was achieved by oxygen-glucose deprivation (OGD). Co-cultures were transferred into a temperature-controlled (37° ± 1°C) hypoxic chamber (in vivo2, UK) at the following gases concentration:
. Once in the hypoxic chamber, the culture medium was replaced with glucose-free medium that had been previously placed in a petri dish and left open overnight in the hypoxic chamber to deoxygenate. After the OGD period, medium was replaced with normoglycemic medium and the cells were returned to a normoxic incubator (reoxygenation) for up to 48h. In control co-cultures the medium was replaced with fresh complete culture medium and the cells were not exposed to OGD.
Immunofluorescence
BMECs on transwell inserts were fixed with ice-cold ethanol for 30min at 4°C and mixed astroglial cell cultures were fixed with 4% PAF for 15min at room temperature. The following primary antibodies were used: rabbit anti-ZO-1 (1:100; Zymed, CA, USA); rabbit anti-claudin-5 (1:100; Zymed, CA, USA); rat anti-CD31 (1:100; Chemicon, MA, USA); mouse anti-GFAP (1:100; Chemicon, MA, USA ); rat anti-CD11b (1:100; kindly provided by Dr. A. Doni) and mouse anti-APC (1:200; Calbiochem, Germany) overnight at 4°C. The secondary antibody used were: anti-rabbit Alexa 594 (1:100, Molecular probe, CA, USA), anti-rat Alexa 488 (1:100, Molecular probe, CA, USA), antimouse Alexa 488. The nuclei were revealed by 10 µg/ml 2,3 bis-benzimides (Sigma, MO, USA) for 10min. Immunofluorescent stainings were acquired by an Olympus IX81 microscope equipped with an Olympus confocal scan unit FV500.
RNA isolation, cDNA synthesis and real-time PCR
Forty-eight hours after pMCAo or sham operation, mice were sacrificed for gene expression analysis as previously described 9 . Brains were rapidly removed and lesioned side cortex dissected and frozen on dry ice. Total RNA was obtained from tissue specimen and from glial cell cultures using the Trizol reagent (Gibco BRL, MD). Samples of total RNA (1.5 μg) were reverse transcripted with random hexamer primers using Multi-Scribe Reverse Transcriptase (TaqMan Reverse transcription reagents, Applied Biosystems, Foster City, CA). Real-time PCR was conducted according to manifacturer instructions by using a GeneAmp 5700 Sequence Detection System (Applied Biosystems Foster City, CA, USA). Real-time PCR was conducted in triplicate with each of the RNA samples 10 . The amplified transcripts were quantified using the comparative cycle threshold method (Applied Biosystems users bulletin #2). β-actin was used as reference gene and relative gene expression levels were determined according to manufacturer's ΔΔCt method (Applied Biosystems). Primers were designed using Primer Express 3.0 software (Applied Biosystems, Foster City, CA) and reported in Table S1 . 
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